Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
Plos One
|
December 20, 2012
Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage
Ramiro Diz, Alaina Garland, Benjamin G Vincent, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 2011
Inducible adeno-associated virus-mediated IL-2 gene therapy prevents autoimmune diabetes
Kevin S Goudy, Mark C Johnson, Alaina Garland, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 4, 2016
Antibody Binding to CD4 Induces Rac GTPase Activation and Alters T Cell Migration
Y Maurice Morillon, Elizabeth Chase Lessey-Morillon, Matthew Clark, et al.
Human Gene Therapy
|
March 29, 2013
Kinetics of adeno-associated virus serotype 2 (AAV2) and AAV8 capsid antigen presentation in vivo are identical
Yi He, Marc S Weinberg, Matt Hirsch, et al.
European Journal of Immunology
|
April 7, 2011
Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity
Kevin S Goudy, Mark C Johnson, Alaina Garland, et al.
European Journal of Immunology
|
August 7, 2012
IFN-γ receptor deficiency prevents diabetes induction by diabetogenic CD4+, but not CD8+, T cells
Zuoan Yi, Li Li, Alaina Garland, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 8, 2003
NF-kappa B hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages
Pradip Sen, Sandip Bhattacharyya, Mark Wallet, et al.
Diabetes
|
February 24, 2007
The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice
Shannon M Pop, Carmen P Wong, Qiuming He, et al.
Diabetes
|
July 26, 2013
β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice
Mark C Johnson, Alaina L Garland, Sarah C Nicolson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 27, 2014
IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cells
Masayuki Mizui, Tomohiro Koga, Linda A Lieberman, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
Plos One
|
December 20, 2012
Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage
Ramiro Diz, Alaina Garland, Benjamin G Vincent, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 2011
Inducible adeno-associated virus-mediated IL-2 gene therapy prevents autoimmune diabetes
Kevin S Goudy, Mark C Johnson, Alaina Garland, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 4, 2016
Antibody Binding to CD4 Induces Rac GTPase Activation and Alters T Cell Migration
Y Maurice Morillon, Elizabeth Chase Lessey-Morillon, Matthew Clark, et al.
Human Gene Therapy
|
March 29, 2013
Kinetics of adeno-associated virus serotype 2 (AAV2) and AAV8 capsid antigen presentation in vivo are identical
Yi He, Marc S Weinberg, Matt Hirsch, et al.
European Journal of Immunology
|
April 7, 2011
Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity
Kevin S Goudy, Mark C Johnson, Alaina Garland, et al.
European Journal of Immunology
|
August 7, 2012
IFN-γ receptor deficiency prevents diabetes induction by diabetogenic CD4+, but not CD8+, T cells
Zuoan Yi, Li Li, Alaina Garland, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 8, 2003
NF-kappa B hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages
Pradip Sen, Sandip Bhattacharyya, Mark Wallet, et al.
Diabetes
|
February 24, 2007
The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice
Shannon M Pop, Carmen P Wong, Qiuming He, et al.
Diabetes
|
July 26, 2013
β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice
Mark C Johnson, Alaina L Garland, Sarah C Nicolson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 27, 2014
IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cells
Masayuki Mizui, Tomohiro Koga, Linda A Lieberman, et al.
Page
of 6